Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Pentagon City Hotel

Mar 12, 2024 7:30 AM - Mar 13, 2024 3:55 PM

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Register Today





Power Learning Session 3: Pharma Marketing and the Role of BBB National Programs’ National Advertising Division

Session Chair(s)

Bob  Dean, MBA

Bob Dean, MBA

Head of Global Labeling Strategy & Ad/Promo

EMD Serono, United States

Join this session to gain insight into how to uphold industry standards in pharmaceutical advertising from the National Programs’ National Advertising Division's (NAD). We will explore a recent case study where the NAD took action to remove misleading drug claims, offering a real-world example of their commitment to consumer protection. Discover how NAD's rigorous examination of pharmaceutical promotions ensures accurate information and safeguards public health. This session is an opportunity to learn about NAD's vital role and how it can be a resource in maintaining transparency and building integrity in the pharmaceutical sector.

Learning Objective :
  • Describe BBB National Programs and NAD’s role in Pharma promotion
  • Compare NAD actions with those of the FDA’s OPDP
  • Apply newly acquired knowledge with internal stakeholders


Laura  Brett

Pharma Marketing and the role of BBB National Programs’ National Advertising Division: Laura Brett

Vice President, National Advertising Division

BBB National Programs, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.